$DGX (Quest Diagnostics Inc.)

$DGX {{ '2015-07-23T12:10:57+0000' | timeago}} • Announcement

$DGX 2Q15 PR: Net revenues for the quarter were $1,925MM compared to $1,902MM in 2Q14, grew by 1.2% versus the prior year and grew 0.8% on an organic basis. Net income attributable to Quest Diagnostics was $118MM compared to $133MM in 2Q14. Adjusted net income for the quarter was $170MM compared to $157MM in 2Q14.

$DGX {{ '2017-12-12T17:19:29+0000' | timeago}} • Announcement

$DGX completed the previously announced acquisition of the Shiel Medical Laboratory business from Fresenius Medical Care, the company focused on delivering care to people with renal and other chronic conditions.

$DGX {{ '2017-12-01T19:47:03+0000' | timeago}} • Announcement

$DGX said it completed the acquisition of Cleveland HeartLab. Pursuant to the deal, Quest has entered into collaboration with Cleveland Clinic to speed up commercialization of emerging innovations at Cleveland, including its Lerner Research Institute. The companies also plan to collaborate on clinical trials.

$DGX {{ '2017-11-29T12:27:19+0000' | timeago}} • Announcement

$DGX has declared a quarterly cash dividend of $0.45 per share on its common stock. The dividend is payable on January 24, 2018, to shareholders of record on January 9, 2018.

$DGX {{ '2017-10-19T15:30:33+0000' | timeago}} • Announcement

$DGX narrowed its FY17 outlook due to the impact of hurricanes in 3Q17. Revenue is now expected to be about $7.71Bil from the previous guidance of $7.69-7.74Bil. GAAP EPS is now expected in the range of $4.87-4.92, down from the earlier range of $4.90-5.00. On an adjusted basis, $DGX narrowed its FY17 EPS outlook to $5.62-5.67.

$DGX {{ '2017-10-19T15:24:48+0000' | timeago}} • Announcement

$DGX earnings plunged for 3Q17 on operating income decline and expense increase. Net earnings declined 16.1% to $161MM or $1.15 per share from $192MM or $1.34 per share a year earlier. Revenue for the quarter rose 2.4% to $1.93Bil. On an adjusted basis, $DGX earned $1.39 per share.

$DGX {{ '2017-10-19T14:18:39+0000' | timeago}} • Infographic

$DGX Quest Diagnostics Incorporated Earnings AlphaGraphic: Q3 2017 Highlights

$DGX {{ '2017-10-18T21:05:30+0000' | timeago}} • Announcement

Medical diagnostic company $DGX has agreed to acquire Cleveland HeartLab from equity investors. The company intends to set up a national center of excellence in diagnostic information services at Cleveland HeartLab's laboratory. The all-equity transaction is expected to close in 4Q17. The financial details of the deal were not disclosed.

$DGX {{ '2017-09-29T14:36:00+0000' | timeago}} • Announcement

Diagnostics firm $DGX acquired the outreach lab services operations of William W Backus Hospital and The Hospital of Central Connecticut, both run by Hartford HealthCare. The acquisition is expected to enable physicians and patients to directly access Quest's broader range of testing services. Financial terms of the deal were not disclosed

$DGX {{ '2017-09-28T13:31:56+0000' | timeago}} • Announcement

$DGX, provider of diagnostic information services, has announced an agreement under which it will acquire the Shiel Medical Laboratory business from $FMS. The transaction is structured as a purchase of assets and expected to be completed in 4Q17. Financial terms were not disclosed.

$DGX {{ '2017-09-27T20:44:38+0000' | timeago}} • Announcement

Diagnostic information services provider $DGX said it expects a 1.5% reduction in revenues and a $0.10 per share impact on both reported and adjusted earnings in 3Q17, due to the recent hurricanes.  The impact of the hurricanes is primarily attributable to operations in Florida and Texas, where the company has a large presence.

$DGX {{ '2017-08-18T14:15:24+0000' | timeago}} • Announcement

$DGX declared a quarterly cash dividend of $0.45 per share, payable on Oct 18, 2017 to shareholders as on Oct 3, 2017.

$DGX {{ '2017-07-18T13:54:10+0000' | timeago}} • Announcement

Medical diagnostics firm $DGX has completed the acquisition of laboratory businesses Med Fusion and Clear Point. They form the basis for Quest’s first national center of excellence in precision diagnostics for oncology. The company is now a preferred provider to several organizations that are formerly owners of one or both of the acquired entities.

$DGX {{ '2017-06-27T17:25:22+0000' | timeago}} • Announcement

$DGX signed a nonbinding letter of intent to buy the outreach laboratory services business of Cape Cod Healthcare (CCHC) for undisclosed terms. Upon approval by the Massachusetts Health Policy Commission, the organizations expect to complete the transaction by Jan. 1, 2018.

$DGX {{ '2017-06-12T20:40:28+0000' | timeago}} • Announcement

$DGX to acquire two laboratory businesses in Lewisville, Texas, aiming to establish a center of excellence providing diagnostic services to aid the detection and management of cancer for oncologists and patients. Upon transaction completion, $DGX will be a preferred provider of advanced oncology diagnostics for US Oncology Network.

$DGX {{ '2017-05-16T16:20:25+0000' | timeago}} • Announcement

$DGX declared a quarterly cash dividend of $0.45 per share, payable on July 24, 2017 to shareholders of record of Quest Diagnostics common stock on July 10, 2017.

$DGX {{ '2017-04-20T14:12:14+0000' | timeago}} • Webcast

$DGX said that its partnership with their computing partner $IBM is progressing well in oncology business. The company said that it uses IBM Watson Health in the cancer treatment. $DGX believes IBM's sales force and their presence with integrated delivery systems will help the company.

$DGX {{ '2017-04-20T13:45:15+0000' | timeago}} • Webcast

$DGX said that its relationship with United Healthcare, which was announced in 4Q16, is progressing well. The company is working with United in wellness and professional laboratory services businesses. $DGX believes that its relationship with United will get stronger over time.

$DGX {{ '2017-04-20T12:38:29+0000' | timeago}} • Announcement

$DGX raised its outlook for EPS in FY17 to $4.73-4.88 from the previous guidance of $4.65-4.80. Adjusted EPS was also raised to $5.45-5.60. The upgrades reflect higher-than-expected excess tax benefit related to stock-based compensation in 1Q17.

$DGX {{ '2017-04-20T12:32:08+0000' | timeago}} • Announcement

Clinical laboratory services company $DGX posted a 2% rise in net revenue in 1Q17 to $1.89Bil. Net income attributable to $DGX was $164MM, or $1.16 per share, compared to $103MM, or $0.61 per share in the year-ago quarter. Adjusted for one-off items, EPS was $1.33.

$DGX {{ '2017-02-21T15:32:26+0000' | timeago}} • Announcement

$DGX's BoD declared a quarterly cash dividend of $0.45 per share, payable on April 19, 2017 to shareholders of record of common stock on April 5, 2017.

Recent Transcripts

IBM (International Business Machines Corporation)
Thursday, January 18 2018 - 10:00pm
ENZ (Enzo Biochem Inc.)
Friday, December 8 2017 - 1:30pm
COO (The Cooper Companies Inc.)
Thursday, December 7 2017 - 10:00pm
PDCO (Patterson Companies, Inc.)
Tuesday, November 21 2017 - 3:00pm
RDNT (RadNet, Inc.)
Thursday, November 9 2017 - 3:30pm
HOLX (Hologic Inc.)
Wednesday, November 8 2017 - 9:30pm
DVA (DaVita HealthCare Partners Inc.)
Tuesday, November 7 2017 - 10:00pm
MYGN (Myriad Genetics, Inc.)
Tuesday, November 7 2017 - 9:30pm
QGEN (Qiagen NV)
Tuesday, November 7 2017 - 2:00pm
ZIOP (ZIOPHARM Oncology, Inc.)
Monday, November 6 2017 - 9:30pm
VCYT (Veracyte, Inc.)
Monday, November 6 2017 - 9:30pm
CVS (CVS Health Corporation)
Monday, November 6 2017 - 1:30pm
EBS (Emergent BioSolutions, Inc.)
Thursday, November 2 2017 - 9:00pm
GNMK (GenMark Diagnostics, Inc.)
Thursday, November 2 2017 - 8:30pm
CI (Cigna Corp.)
Thursday, November 2 2017 - 12:30pm
ADP (Automatic Data Processing Inc)
Thursday, November 2 2017 - 12:30pm
QDEL (Quidel Corp.)
Wednesday, November 1 2017 - 9:00pm
EVHC (Envision Healthcare Holdings, Inc.)
Wednesday, November 1 2017 - 12:30pm
WCG (WellCare Health Plans, Inc.)
Tuesday, October 31 2017 - 1:30pm
RDY (Dr. Reddy's Laboratories Ltd.)
Tuesday, October 31 2017 - 1:00pm

AlphaGraphics you may like